Wirtz was the first to establish how a three-dimensional environment fundamentally affects the way cancer cells migrate, providing more biologically and medically relevant information than two-dimensional studies.[2] He also pioneered the technique of particle-tracking microrheology to probe the rheological properties of complex fluids and living cells and tissues. He is a professor in the Departments of Chemical Engineering & Biomolecular Engineering and Materials Science & Engineering in the Whiting School of Engineering, and in the Departments of Oncology and Pathology in the Johns Hopkins School of Medicine.[3]
Wirtz was named vice provost for research in February 2014, charged with directing the university's $2.24 billion research enterprise,[4][5] implementing institutional research compliance, expanding research development,[6] and producing and managing cross-divisional research initiatives, such as the Johns Hopkins Catalyst and Discovery Awards program,[7][8] the President's Frontier Award program,[9] and the Bloomberg Distinguished Professorships,[10] which were established as part of a $350 million gift by Michael Bloomberg.[11][12][13]
Wirtz joined the faculty of the Department of Chemical and Biomolecular Engineering at Johns Hopkins University in 1994 and was promoted to the rank of full professor in 2003. In 2009, he was selected to be the Theophilus Halley Smoot Professor of Engineering Science[16] with secondary appointments in the departments of Materials Science and Engineering,[17] Pathology and Oncology, where he collaborates with fellow researchers in the Sidney Kimmel Comprehensive Cancer Center.[18][19]
Upon his appointment as the Theophilius Halley Smoot Professor of Engineering Physics, [20][21] Dr. Nicholas Jones, former dean of the Whiting School of Engineering, stated
"Throughout his time at Johns Hopkins, Denis has distinguished himself as an outstanding scholar and teacher. Additionally, Denis’ role as a catalyst for interdisciplinary research and collaboration at the university has proven extremely effective, both in terms of the research he conducts and the support he has attracted over the years. I am confident that his current research into the physical basis for cell adhesion and de-adhesion will prove critical to our understanding of the metastasis of cancer and enable important breakthroughs in the diagnosis and treatment of cancer in the years to come."[22]
In February 2014, Wirtz was named the vice provost for research at Johns Hopkins . In announcing the Wirtz's appointment, Provost Robert C. Lieberman stated,
"As is obvious to all who know him, Denis is an extremely productive and accomplished faculty member and a wonderful colleague. Those traits will serve both Denis and the university as he works with me to support important multidisciplinary research projects, including the strategic initiatives identified in the campaign, the Bloomberg Distinguished Professorships, and multidivisional proposals in response to RFAs (requests for applications)."[23]
Vice provost
In his role as vice provost for research, Wirtz has recruited nearly two dozen faculty to join Johns Hopkins University as Bloomberg Distinguished Professors,[24] managed the inaugural year of the Catalyst and Discovery Awards,[25][26][27] and the first two President's Frontier Awards.[28] He has expanded the university's research development efforts, creating a weekly digest of limited submission opportunities,[29] a list of more than 175 funding opportunities for postdoctoral researchers,[30] a list of more than 330 funding opportunities for early career faculty,[31] and consolidated monthly digests of internal funding opportunities at the institution.[32] He also consolidated multiple research administration offices into a central research administration team, Johns Hopkins University Research Administration.[33] As director of the university's Signature Initiatives, he has overseen the launch of two new signature initiatives on big data, led by Alex Szalay,[34] and space studies, Space@Hopkins, led by Charles L. Bennett.[35] These are in addition to Kathryn Edin’s 21st Century Cities Initiative, Barbara Landau’s Science of Learning Institute, Scott Zeger’s Individualized Health Initiative, and David Peters’ Global Health Signature Initiative.[36]
"For too long, not enough room has been made for nonconventional and nonbiological concepts borrowed from modern physics and engineering to tackle this disease. It is time to bring to the table ideas grounded in chemical and biomolecular engineering principles to develop new therapies and diagnostic tools. [The National Cancer Institute has] given us major funding for a center to study all the steps in the metastatic cascade."[39]
The PSOC is part of the Johns Hopkins Institute for NanoBioTechnology (INBT), which Wirtz co-founded and acts as associate director. INBT was launched in 2006 to "promote multidisciplinary research at the interface of nanotechnology and medicine."[40] With more than 250 affiliated faculty members from the Johns Hopkins schools of Engineering, Arts and Sciences, Medicine, and Public Health and scientists from the Applied Physics Laboratory, the institute is home to several center grants and numerous education, training, and outreach programs. INBT counts Becton Dickinson, MedImmune, Northrop Grumman, Secant Medical, and Under Armour among its corporate partners, and Wirtz has previously served as a Nikon Partner in Science since 2008.[41]
Wirtz is the PI of a National Science Foundation Research Experiences for Undergraduates (REU) site in the Nanotechnology for Biology and Bioengineering program.[42][43] Wirtz also founded the Johns Hopkins Center for Digital Pathology that brings together pathologists, surgeons, oncologists, and engineers to develop new single-cell technology for improved diagnostic, prognostic, therapeutic approaches for human diseases, including cancer, Chronic obstructive pulmonary disease (COPD), and frailty in aging.[44] He co-directs the Cancer Nanotechnology Training Center,[45] another National Cancer Institute-funded entity. From 2005 to 2012, he also directed a Howard Hughes Medical Institute (HHMI) funded interdisciplinary graduate research training program in nanotechnology for biology and medicine. The program aimed to produce researchers able to create new particles and materials to be used in the detection, treatment, prevention, and cure of human disease. It recruited students from biochemistry, chemistry, physics, biology, and engineering, while making a special effort to include minorities under-represented in science.[46]
Awards and distinctions
Wirtz was elected fellow of the American Institute for Medical and Biological Engineering in 2006 for "major contributions in molecular cell mechanics and the development of particle tracking methods for cell and molecular biology."[47] In 2009, he was elected fellow of the American Association for the Advancement of Science in 2009 "for contributions to cell micromechanics and cell adhesion and for the development and application of particle tracking methods to probe the micromechanical properties of living cells in normal conditions and disease state."[48][49] Wirtz was elected fellow of the American Physical Society in 2010 for "his seminal contributions to the understanding of basic cellular functions through the development and application of novel biophysical methods grounded in statistical mechanics and polymer physics."[50] In 2011, he was elected member of the Belgian American Educational Foundation (BAEF).[51]
Wirtz is a 1996 recipient of the National Science FoundationCAREER Award for: “A Research and Teaching Program in Complex Fluids Dynamics.”.[53] In 1997, he received the Whitaker Foundation’s Biomedical Engineering Award.[54][55] In collaboration with Benjamin Shapiro, Elisabeth Smela and Pamela Ann Abshire, Wirtz was awarded the 2004 Physical Science Invention of the Year Award by the University of Maryland Office of Technology Commercialization. The team invented a Cell Sensor Based Pathogen Detection that will enable “selective pathogran detection by exploiting the signalizing machinery of living cells.[56]
Since 2008, he has been the Editor-in-Chief of Cell Health and the Cytoskeleton.[57] He is on the Editorial Boards of Scientific Reports, Cell Adhesion & Migration,[58]World Journal of Biological Chemistry,[59] and TECHNOLOGY.[60] Wirtz formerly served on the editorial boards of Physical Biology, Journal of the Royal Society Interface Focus, Biophysical Journal,[61]Nanomedicine: Nanotechnology, Biology and Medicine, as an ad hoc editor for the Proceedings of the National Academy of Sciences of the United States of America, as the guest editor of a Special Issue of Physical Biology on physical oncology,[62] and as the editor of the Cell Biophysics section of Comprehensive Biophysics.[63][64] Wirtz also served as an expert advisor to the study panel of the international Assessment of Physical sciences and Engineering advances in Life sciences and Oncology (APHELION), which was commissioned by the National Cancer Institute and National Science Foundation in order to “determine the status and trends of applying physical sciences and engineering principles to oncology research and development in leading laboratories and organizations in Europe via an on-site peer review process.”[65]
Bridging the fields of chemical engineering, oncology, pathology, biophysics, and materials science, Wirtz's research focuses on the biophysical properties of healthy and diseased cells, including interactions between adjacent cells and the role of cellular architecture on nuclear shape and gene expression.[75] His research interests include cell biophysics, aging, tumor microenvironment, digital pathology, the actin cap, single molecule manipulation, intracellular particle trafficking, instrument development, tissue engineering, and nanotechnology in biology and medicine.[76] He has made important contributions to molecular and biophysical mechanisms of cell motility and adhesion and nuclear dynamics in health and disease, and he pioneered the method of particle-tracking microrheology to probe the rheological properties of complex fluids and living cells and tissues.[77]
Wirtz currently holds several patents on his work.[78]
2009, B. Wildt, D. Wirtz, and P.C. Searson, Programmed sub-cellular release for studying the dynamics of cell detachment, in: Nature Methods. Vol. 6; 211–213.
2010, S.I. Fraley, Y. Feng, D.H. Kim, A. Celedon, G.D. Longmore, and D. Wirtz, The distinctive role of focal adhesion proteins in three-dimensional cell motility, in: Nature Cell Biology. Vol. 12; 598–604.
2011, D. Wirtz, K. Konstantopoulos, P.C. Searson, The physics of cancer: the role of physical interactions and mechanical forces in metastasis, in: Nature Reviews Cancer. Vol. 11; 512–522.
2012, S.I. Fraley, Y. Feng, A. Giri, G.D. Longmore, and D Wirtz, Dimensional and temporal controls of three-dimensional cell migration by Zyxin and binding partners, in: Nature Communications. Vol. 3; 719.
2013, K. Konstantopoulos, P.-H. Wu, and D. Wirtz, Dimensional control of cancer cell migration, in: Biophysical Journal. Vol. 104, nº 2; 279–280.
2014, D.M. Gilkes, L. Xiang, S.J. Lee, M.E. Hubbi, P. Chaturvedi, D. Wirtz, and G.L. Semenza, Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells, in: PNAS. Vol. 111; E384-E393.
2014, P.H. Wu, A. Giri, S.X. Sun, D. Wirtz, Three-dimensional cell migration does not follow a random walk, in: PNAS. Vol. 111, nº 11; 3949–3954.
2015, P.-H. Wu, A. Giri, and D. Wirtz, Statistical analysis of cell migration in 3D using the anisotropic persistent random walk model, in: Nature Protocols. Vol. 10; 517–527.
2009, S.B. Khatau, C.M. Hale, P.J. Stewart-Hutchison, M.S. Patel, C.L. Stewart, P.C. Searson, D. Hodzic, and D. Wirtz, A perinuclear actin cap regulates nuclear shape, in: PNAS. Vol. 107; 19017–19022.
2013, D.H. Kim, A.B. Chambliss, and D. Wirtz, The multi-faceted role of the actin cap in cellular mechanosensation and mechanotransduction, in: Soft Matter. Vol. 9; 5516–5523.
2013, A.B. Chambliss, S.B. Khatau, P.-H. Wu, N. Erdenberger, D.K. Robinson, D. Hodzic, G.D. Longmore, and D. Wirtz, The LINC-anchored actin cap connects the extracellular milieu to the nucleus for ultrafast mechanotransduction, in: Scientific Reports. Vol. 3; 1087–1095.
2013, S.B. Khatau, R.J. Bloom, S. Bajpai, D. Razafsky, S. Zang, A. Giri, P.-H. Wu, J. Marchand, A. Celedon, C.M. Hale, S.X. Sun, D. Hodzic, and D. Wirtz, The distinct roles of the nucleus and nucleus-cytoskeleton connections in three-dimensional cell migration, in: Scientific Reports. Vol. 2; 488–499.
2014, D.H. Kim, S. Cho, and D. Wirtz, Tight coupling between nucleus and cell migration through the perinuclear actin cap, in: Journal of Cell Science. Vol. 127; 2528–2541.
2008, S. Bajpai, J. Correia, Y. Feng, J. Figueiredo, S.X. Sun, G.D. Longmore, G. Suriano, and D. Wirtz, a-catenin mediates initial E-cadherin-dependent cell-cell recognition and subsequent bond strengthening, in: PNAS. Vol. 105; 18331–18336.
2009, S. Bajpai, Y. Feng, R. Krishnamurthy, G.D. Longmore, and D. Wirtz, Loss of a-catenin decreases the strength of single E-cadherin bonds between human cancer cells, in: Journal of Biological Chemistry. Vol. 284; 18252–18259.
2011, P.S. Raman, C.S. Alves, D. Wirtz, K. Konstantopoulos, Single molecule binding of CD44 to fibrin versus P-selectin predicts their distinct shear-dependent interactions in cancer, in: Journal of Cell Science. Vol. 124; 1904–1910.
2013, S. Bajpai, Y. Feng, D. Wirtz, and G.D. Longmore, a-catenin serves as a clutch between low and high intercellular E-cadherin bond strengths, in: Biophysical Journal. Vol. 105; 2289–2300.
Publications
Wirtz has published nearly 200 peer-reviewed articles published in Science, Nature, Nature Cell Biology, Nature Methods, Nature Reviews Cancer, Nature Materials, Nature Protocols, PNAS, Nature Communications, and Journal of Cell Biology. He has an h-index of 83.[79]
Cadherins (named for "calcium-dependent adhesion") are cell adhesion molecules important in forming adherens junctions that let cells adhere to each other. Cadherins are a class of type-1 transmembrane proteins, and they depend on calcium (Ca2+) ions to function, hence their name. Cell-cell adhesion is mediated by extracellular cadherin domains, whereas the intracellular cytoplasmic tail associates with numerous adaptors and signaling proteins, collectively referred to as the cadherin adhesome.
The Max Planck Institute of Biochemistry is a research institute of the Max Planck Society located in Martinsried, a suburb of Munich. The institute was founded in 1973 by the merger of three formerly independent institutes: the Max Planck Institute of Biochemistry, the Max Planck Institute of Protein and Leather Research, and the Max Planck Institute of Cell Chemistry.
Cell migration is a central process in the development and maintenance of multicellular organisms. Tissue formation during embryonic development, wound healing and immune responses all require the orchestrated movement of cells in particular directions to specific locations. Cells often migrate in response to specific external signals, including chemical signals and mechanical signals. Errors during this process have serious consequences, including intellectual disability, vascular disease, tumor formation and metastasis. An understanding of the mechanism by which cells migrate may lead to the development of novel therapeutic strategies for controlling, for example, invasive tumour cells.
Molecular biophysics is a rapidly evolving interdisciplinary area of research that combines concepts in physics, chemistry, engineering, mathematics and biology. It seeks to understand biomolecular systems and explain biological function in terms of molecular structure, structural organization, and dynamic behaviour at various levels of complexity. This discipline covers topics such as the measurement of molecular forces, molecular associations, allosteric interactions, Brownian motion, and cable theory. Additional areas of study can be found on Outline of Biophysics. The discipline has required development of specialized equipment and procedures capable of imaging and manipulating minute living structures, as well as novel experimental approaches.
Alfredo Quiñones-Hinojosa is a Mexican-American neurosurgeon, author, and researcher. Currently, he is the William J. and Charles H. Mayo Professor and Chair of Neurologic Surgery and runs a basic science research lab at the Mayo Clinic Jacksonville in Florida.
Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. In August 2021, Simons was appointed the medical director and Chief Science Officer of the Marcus Foundation. Prior to joining the Marcus Foundation, he served a 14-year tenure as the President and chief executive officer of the Prostate Cancer Foundation. Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer. The Simons lab invented GM-CSF genetically engineered vaccines for prostate cancer in rodents and humans for these studies, and subsequently Simons’ clinical team took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins.
Single-particle tracking (SPT) is the observation of the motion of individual particles within a medium. The coordinates time series, which can be either in two dimensions (x, y) or in three dimensions (x, y, z), is referred to as a trajectory. The trajectory is typically analyzed using statistical methods to extract information about the underlying dynamics of the particle. These dynamics can reveal information about the type of transport being observed (e.g., thermal or active), the medium where the particle is moving, and interactions with other particles. In the case of random motion, trajectory analysis can be used to measure the diffusion coefficient.
The Koch Institute for Integrative Cancer Research at MIT is a cancer research center affiliated with the Massachusetts Institute of Technology (MIT) located in Cambridge, Massachusetts, United States. The institute is one of seven National Cancer Institute-designated basic laboratory cancer centers in the United States.
The following outline is provided as an overview of and topical guide to biophysics:
Taekjip Ha is a South Korean-born American biophysicist who is currently a Bloomberg Distinguished Professor of Biophysics and Biomedical Engineering at Johns Hopkins University. He was previously the Gutgsell Professor of Physics, at University of Illinois at Urbana-Champaign where he was the principal investigator of Single Molecule Nanometry group. He is also a Howard Hughes Medical Institute investigator.
The Physical Sciences in Oncology Network (PS-ON) is a network of centers and projects set up by the National Institutes of Health (NIH) National Cancer Institute (NCI) to link the physical sciences with the study of cancer. The program was launched in 2009 with Physical Sciences in Oncology Centers (PS-OCs) investigating complex and challenging questions in cancer research from a physical sciences perspective. To explore how the NCI could continue to support the integration of physical sciences and cancer research, a Think Tank and series of Strategic Workshops were held in 2012. These meetings served to update opportunities at the interface of physical sciences and cancer research and guided the development of the second phase including Physical Sciences in Oncology Projects (PS-OPs).
Rong Li is the Director of Mechanobiology Institute, a Singapore Research Center of Excellence, at the National University of Singapore. She is a Distinguished Professor at the National University of Singapore's Department of Biological Sciences and Bloomberg Distinguished Professor of Cell Biology and Chemical & Biomolecular Engineering at the Johns Hopkins School of Medicine and Whiting School of Engineering. She previously served as Director of Center for Cell Dynamics in the Johns Hopkins School of Medicine’s Institute for Basic Biomedical Sciences. She is a leader in understanding cellular asymmetry, division and evolution, and specifically, in how eukaryotic cells establish their distinct morphology and organization in order to carry out their specialized functions.
Clare M. Waterman is a cell biologist who has worked on understanding the role of the cytoskeleton in cell migration. Waterman is a Distinguished Investigator, Chief of the Laboratory of Cell and Tissue Morphodynamics, and Director of the Cell and Developmental Biology Center at the National Heart, Lung, and Blood Institute (NHLBI), in the National Institutes of Health (NIH) in Bethesda MD, USA. Waterman has received several awards and honors, including the Sackler International prize in Biophysics, the NIH Director’s Pioneer Award, and the Arthur S. Flemming Award for Public Service. In 2018, she was elected to the National Academy of Sciences. She currently serves on the editorial boards of eLife, Current Biology and Journal of Microscopy.
Jin Zhang is a Chinese-American biochemist. She is a professor of pharmacology, chemistry and biochemistry, and biomedical engineering at the University of California, San Diego.
Ravi Salgia is a translational thoracic oncologist, clinician/scientist, and academician.
Christopher S. Chen, born in 1968, is an American biological engineer. He is the William Fairfield Warren Distinguished Professor of Biomedical Engineering at Boston University and member of the Wyss Institute for Biologically Inspired Engineering at Harvard University in Boston.
Yan Xiyun is a Chinese nanobiologist, academician of the Chinese Academy of Sciences, researcher and doctoral supervisor of the Institute of Biophysics, and professor of the University of the Chinese Academy of Sciences. Her main accomplishment was the discovery of nanozymes and its application in tumor diagnosis.
Maura Lianne Gillison is an American medical oncologist and molecular epidemiologist. She is credited as the first investigator to establish a connection between HPV and oral cancer.
Andrew Ewald is a professor of cell biology at Johns Hopkins University School of Medicine. He is known for his contributions in the field of metastatic breast cancer research.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
